Dana-Farber Cancer Institute: Advances in Systemic Mastocytosis - Early Signs of Efficacy for a Novel Drug and a New Predictive Tool to Guide Patient Care
December 10, 2024
December 10, 2024
BOSTON, Massachusetts, Dec. 10 (TNSres) -- The Dana-Farber Cancer Institute issued the following news release:
Dana-Farber Cancer Institute researchers are breaking new ground in the fight against systemic mastocytosis, a rare and heterogeneous condition that is often challenging for clinicians to accurately diagnose and treat.
Researchers presented promising results from two studies at the 66th American Society for Hematology (ASH) Annual Meeting and Exposition: one sh . . .
Dana-Farber Cancer Institute researchers are breaking new ground in the fight against systemic mastocytosis, a rare and heterogeneous condition that is often challenging for clinicians to accurately diagnose and treat.
Researchers presented promising results from two studies at the 66th American Society for Hematology (ASH) Annual Meeting and Exposition: one sh . . .